Encompass Health (EHC) Fundamental Analysis: Revenue, Earnings & Valuation

6.88 / 10

Outperform

Fundamentally, EHC scores 6.9/10. Strengths include high Cash‑MV (0.34), strong Asset‑MV (‑0.55) and Revenue‑MV (0.37) differentials, and robust YoY profit growth (27%). Weak points are modest PB‑ROE (0.45) and limited Cash‑UP (0.13), tempering the upside.

Analysis Checks(6/10)

Revenue-MV

Value0.37

Score3/3

Weight25.50%

1M Return7.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value18.14

Score1/3

Weight2.31%

1M Return0.81%

PB-ROE

Value0.45

Score1/3

Weight-0.99%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value24.06

Score2/3

Weight4.64%

1M Return1.70%

Total profit (YoY growth rate %)

Value27.13

Score2/3

Weight5.43%

1M Return1.87%

Net cash flow from operating activities (YoY growth rate %)

Value17.23

Score1/3

Weight2.71%

1M Return1.00%

Cash-UP

Value0.13

Score1/3

Weight1.83%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value24.22

Score2/3

Weight3.40%

1M Return1.25%

Asset-MV

Value-0.55

Score3/3

Weight32.38%

1M Return9.13%

Cash-MV

Value0.34

Score3/3

Weight22.80%

1M Return6.61%

Is EHC fundamentally strong?

EHC scores 6.88/10 on fundamentals and holds a Discounted valuation at present. Backed by its 18.49% ROE, 12.79% net margin, 17.13 P/E ratio, 2.96 P/B ratio, and 24.06% earnings growth, these metrics solidify its Outperform investment rating.